Core Insights - Catalent, Inc. has unveiled a new corporate brand that emphasizes its commitment to customer service and supporting important missions in healthcare [1][2] - The rebranding comes after Catalent's transition to private ownership under Novo Holdings in December 2024, and coincides with the establishment of its new global headquarters in Tampa, Florida [2] Company Strategy - The new branding reflects Catalent's dedication to putting patients first and providing tailored solutions with exceptional service [3] - The company aims to align its identity with the unique experiences that differentiate it in the market [3] Operational Highlights - Catalent has supported the development and manufacture of products that account for half of all FDA approvals over the past decade [3] - The company produces over 60 billion doses annually and manages over 1,000 active development programs at any given time [3] - Catalent collaborates with a diverse range of customers, from small organizations to large global companies, adapting its approach to meet specific program needs [3]
Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by "Championing the Missions that Matter™"